Renishaw Regulatory News (RSW)

9 Jul 2007 16:30

Renishaw PLC09 July 2007 Renishaw plc 9 July 2007 Renishaw invests in D3 Technologies Limited Renishaw is pleased to announce it has acquired a 75% interest in D3Technologies Limited ("D3"), a company set up in collaboration with theUniversity of Strathclyde and others to exploit certain patents related toSurface Enhanced Raman Spectroscopy ("SERS") and to develop SERS for moleculardiagnostics and trace detection. Renishaw's investment in D3 will comprise cash of £1.85 million andinstrumentation, with a combined value of approximately £5m over the next 5years. Part of the investment has been used by D3 to purchase for £850,000 the businessand assets of the analytical business unit ("ABU") operated by MesophotonicsLimited, a spin-out company from the University of Southampton. The ABU developsand manufactures substrates used in SERS applications. Combining the SERS technology and biochemistry expertise of the University ofStrathclyde with the Klarite(c) substrate technology of Mesophotonics ABU offersa broad range of product opportunities to exploit in the growing healthcarediagnostics and forensic markets. As a leading supplier of Raman instrumentation Renishaw has a vested interest inthe furtherance of Raman spectroscopy and its applications into new anddeveloping markets. Renishaw's principal business is the design, manufacture and sale of advancedprecision metrology and inspection equipment and analytical systems. Over 90% ofits sales are exported internationally through its world-wide network ofsubsidiaries and distributors. Renishaw's sales for the financial year ended 30June 2006 were £175.8m. SIR DAVID R McMURTRY CBE RDI CEng FIMechE FREngChairman and Chief ExecutiveRenishaw plc Enquiries: A C G Roberts 01453 524445 B R Taylor 01453 524445 Registered office: New Mills, Wotton-under-Edge, Gloucestershire. GL12 8JR Telephone: 01453 524524 www.renishaw.com This information is provided by RNS The company news service from the London Stock Exchange